Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 2 |
2022 | 3 |
2023 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Comparative analysis of immune checkpoint inhibitors in first-line treatment of esophageal squamous cell carcinoma: a network meta-analysis.
Immunotherapy. 2023 Jul;15(10):737-750. doi: 10.2217/imt-2022-0236. Epub 2023 May 4.
Immunotherapy. 2023.
PMID: 37139963
A Meta-analysis of Total Neoadjuvant Therapies Combining Chemoradiotherapy with Induction or Consolidated Chemotherapy for Locally Advanced Rectal Cancer.
Nov P, Du K, Huang Z, Li Y, Gong M, Liu X, Li C, Li L, Wang D, Zhang Y, Wang C, Li J.
Nov P, et al. Among authors: zhang y.
J Gastrointest Cancer. 2023 Sep;54(3):693-702. doi: 10.1007/s12029-022-00864-6. Epub 2022 Oct 15.
J Gastrointest Cancer. 2023.
PMID: 36243897
Review.
Item in Clipboard
Inhibition of sphingolipid metabolism in osteosarcoma protects against CD151-mediated tumorigenicity.
Wang H, Jin X, Zhang Y, Wang Z, Zhang T, Xu J, Shen J, Zan P, Sun M, Wang C, Hua Y, Ma X, Sun W.
Wang H, et al. Among authors: zhang y.
Cell Biosci. 2022 Oct 8;12(1):169. doi: 10.1186/s13578-022-00900-9.
Cell Biosci. 2022.
PMID: 36209197
Free PMC article.
Item in Clipboard
Her4 promotes cancer metabolic reprogramming via the c-Myc-dependent signaling axis.
Han J, Zhang Y, Xu J, Zhang T, Wang H, Wang Z, Jiang Y, Zhou L, Yang M, Hua Y, Cai Z.
Han J, et al. Among authors: zhang y.
Cancer Lett. 2021 Jan 1;496:57-71. doi: 10.1016/j.canlet.2020.10.008. Epub 2020 Oct 7.
Cancer Lett. 2021.
PMID: 33038488
Item in Clipboard
MYLK4 promotes tumor progression through the activation of epidermal growth factor receptor signaling in osteosarcoma.
Yang M, Zhang T, Zhang Y, Ma X, Han J, Zeng K, Jiang Y, Wang Z, Wang Z, Xu J, Hua Y, Cai Z, Sun W.
Yang M, et al. Among authors: zhang y.
J Exp Clin Cancer Res. 2021 May 12;40(1):166. doi: 10.1186/s13046-021-01965-z.
J Exp Clin Cancer Res. 2021.
PMID: 33980265
Free PMC article.
Item in Clipboard
Integrative Pan-Cancer Analysis Confirmed that FCGR3A is a Candidate Biomarker Associated With Tumor Immunity.
Li L, Huang Z, Du K, Liu X, Li C, Wang D, Zhang Y, Wang C, Li J.
Li L, et al. Among authors: zhang y.
Front Pharmacol. 2022 May 20;13:900699. doi: 10.3389/fphar.2022.900699. eCollection 2022.
Front Pharmacol. 2022.
PMID: 35668930
Free PMC article.
Item in Clipboard
Cite
Cite